These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28387815)

  • 1. Atherosclerotic plaque vulnerability in the statin era.
    Nilsson J
    Eur Heart J; 2017 Jun; 38(21):1638-1644. PubMed ID: 28387815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerable plaque and inflammation: potential clinical strategies.
    Drakopoulou M; Toutouzas K; Michelongona A; Tousoulis D; Stefanadis C
    Curr Pharm Des; 2011 Dec; 17(37):4190-209. PubMed ID: 22204378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerable plaque imaging: updates on new pathobiological mechanisms.
    Toutouzas K; Benetos G; Karanasos A; Chatzizisis YS; Giannopoulos AA; Tousoulis D
    Eur Heart J; 2015 Dec; 36(45):3147-54. PubMed ID: 26419623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential benefits of eicosapentaenoic acid on atherosclerotic plaques.
    Nelson JR; Wani O; May HT; Budoff M
    Vascul Pharmacol; 2017 Apr; 91():1-9. PubMed ID: 28263852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study.
    Chung JW; Hwang J; Lee MJ; Cha J; Bang OY
    Stroke; 2016 Jul; 47(7):1789-96. PubMed ID: 27301946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
    Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
    Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition.
    Janssen H; Wagner CS; Demmer P; Callies S; Sölter G; Loghmani-khouzani H; Hu N; Schuett H; Tietge UJ; Warnecke G; Larmann J; Theilmeier G
    Dis Model Mech; 2015 Sep; 8(9):1071-80. PubMed ID: 26092124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomechanical stress in coronary atherosclerosis: emerging insights from computational modelling.
    Thondapu V; Bourantas CV; Foin N; Jang IK; Serruys PW; Barlis P
    Eur Heart J; 2017 Jan; 38(2):81-92. PubMed ID: 28158723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
    Abela GS
    J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins attenuate the development of atherosclerosis and endothelial dysfunction induced by exposure to urban particulate matter (PM10).
    Miyata R; Hiraiwa K; Cheng JC; Bai N; Vincent R; Francis GA; Sin DD; Van Eeden SF
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):1-11. PubMed ID: 23756175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.
    Edsfeldt A; Gonçalves I; Grufman H; Nitulescu M; Dunér P; Bengtsson E; Mollet IG; Persson A; Nilsson M; Orho-Melander M; Melander O; Björkbacka H; Nilsson J
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2143-50. PubMed ID: 25035341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction.
    Otsuka F; Hibi K; Kusama I; Endo M; Kosuge M; Iwahashi N; Okuda J; Tsukahara K; Ebina T; Kojima S; Sugiyama S; Ogawa H; Umemura S; Kimura K
    Atherosclerosis; 2010 Dec; 213(2):505-11. PubMed ID: 20926078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
    Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
    Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the time course of atherosclerotic plaque regression.
    Noyes AM; Thompson PD
    Atherosclerosis; 2014 May; 234(1):75-84. PubMed ID: 24632041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An emerging paradigm in atherosclerosis: focus on subclinical disease.
    Miller M
    Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis.
    Eilenberg W; Stojkovic S; Kaider A; Kozakowski N; Domenig CM; Burghuber C; Nanobachvili J; Huber K; Klinger M; Neumayer C; Huk I; Wojta J; Demyanets S
    Clin Chem Lab Med; 2017 Nov; 56(1):147-156. PubMed ID: 28672747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin treatment and atherosclerotic plaque stability: Role of adiponectin/APPL1 signaling pathway.
    Barbieri M; Marfella R; Esposito A; Rizzo MR; Angellotti E; Mauro C; Siniscalchi M; Chirico F; Caiazzo P; Furbatto F; Bellis A; D'Onofrio N; Vitiello M; Ferraraccio F; Paolisso G; Balestrieri ML
    J Diabetes Complications; 2017 Feb; 31(2):295-303. PubMed ID: 27771154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.